Plant Comparison

Midland Hawthorn vs Lingzhi

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant

Second plant

Plant AMidland HawthornCrataegus laevigataRosaceaeFull monograph →

Plant BLingzhiGanoderma lingzhiGanodermataceaeFull monograph →

At a glance

Midland Hawthorn and Lingzhi: they share 5 indicated uses (arthritis / joint pain, cardiovascular / heart health, inflammation (general), …); 3 pharmacological actions in common.

Midland HawthornLingzhi

Constituents22

Pharmacological actions47

Indicated uses711

Safety notes22

Cited sources2221

Indicated uses

Only Midland Hawthorn

Menstrual crampsMuscle spasm

Shared (5)

Arthritis / joint painCardiovascular / heart healthInflammation (general)Insomnia / sleeplessnessSkin irritation

Only Lingzhi

Blood sugar / diabetes supportCancer (anticancer research)Cold & fluImmune supportInfection (general)Metabolic support

Pharmacological actions

Only Midland Hawthorn

Antispasmodic

Shared (3)

Anti-inflammatoryAntioxidantSedative / sleep support

Only Lingzhi

Anticancer (preclinical)Antidiabetic (blood-sugar lowering)AntiviralImmunomodulator / immune support

Evidence face-off — shared uses

Condition	Midland Hawthorn	Lingzhi	Verdict
Arthritis / joint pain	1/10	1/10	Comparable evidence
Cardiovascular / heart health	1/10	1/10	Comparable evidence
Inflammation (general)	1/10	1/10	Comparable evidence
Insomnia / sleeplessness	1/10	1/10	Comparable evidence
Skin irritation	1/10	1/10	Comparable evidence

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Oligomeric proanthocyanidins and flavonoids^[5]

The principal cardioactive and antioxidant constituents, the basis for extract standardisation.

ProanthocyanidinsFlavonoidsQuercetin

Phenolic acids

Additional antioxidant constituents of the flower, leaf and fruit.

Phenolic acidsChlorogenic acid

Beta-glucan polysaccharides^{[1, 4]}

Principal immunomodulatory constituents, the main focus of anticancer-adjunct and immune research.

Polysaccharides

Triterpenes (ganoderic acids)^[1]

Bitter triterpenes associated with anti-inflammatory, hepatoprotective and adaptogenic activity.

Triterpene saponinsTerpenes / terpenoids

Pharmacological Actions

Anti-inflammatory^{[9, 15, 16]}

Antioxidant^{[2, 5, 6, 7, 8, 9, 15, 16]}

Antispasmodic^{[2, 10, 11, 15, 16]}

Antispasmodic (cramp easing)

Sedative / sleep support^{[12, 15, 16]}

Anti-inflammatory^{[2, 6, 14, 15, 16]}

Anticancer (preclinical)^{[4, 9, 10, 13, 14, 15, 16]}

Antidiabetic (blood-sugar lowering)^{[5, 9, 14, 15, 16]}

Antioxidant^{[5, 7, 14, 15, 16]}

Antiviral^{[6, 14, 15, 16]}

Immunomodulator / immune support^{[4, 5, 8, 10, 12, 14, 15, 16]}

Sedative / sleep support^{[14, 15, 16]}

Traditional & Indicated Uses

Arthritis / joint pain^{[15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Arthritis / joint pain

Cardiovascular / heart health^{[15, 16]}Traditional · 1/10

Evidence: 1

Label: Cardiovascular / heart health

Inflammation (general)^{[15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Inflammation (general)

Insomnia / sleeplessness^{[15, 16]}Traditional · 1/10

inferred from sedative action

Evidence: 1

Label: Insomnia / sleeplessness

Menstrual cramps^{[15, 16]}Traditional · 1/10

inferred from antispasmodic action

Evidence: 1

Label: Menstrual cramps

Muscle spasm^{[15, 16]}Traditional · 1/10

inferred from antispasmodic action

Evidence: 1

Label: Muscle spasm

Skin irritation^{[15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Skin irritation

Arthritis / joint pain^{[14, 15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Arthritis / joint pain

Blood sugar / diabetes support^{[14, 15, 16]}Traditional · 1/10

inferred from antidiabetic action

Evidence: 1

Label: Blood sugar / diabetes support

Cancer (anticancer research)^{[1, 4, 10, 15]}Good · 8/10

inferred from anticancer action

Evidence: 8

Label: Cancer (anticancer research)

Cardiovascular / heart health^{[14, 15, 16]}Traditional · 1/10

Evidence: 1

Label: Cardiovascular / heart health

Cold & flu^{[14, 15, 16]}Traditional · 1/10

inferred from antiviral action

Evidence: 1

Label: Cold & flu

Immune support^{[14, 15, 16]}Traditional · 1/10

Evidence: 1

Label: Immune support

Infection (general)^{[14, 15, 16]}Traditional · 1/10

inferred from antiviral action

Evidence: 1

Label: Infection (general)

Inflammation (general)^{[14, 15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Inflammation (general)

Insomnia / sleeplessness^{[14, 15, 16]}Traditional · 1/10

inferred from sedative action

Evidence: 1

Label: Insomnia / sleeplessness

Metabolic support^{[14, 15, 16]}Traditional · 1/10

inferred from antidiabetic action

Evidence: 1

Label: Metabolic support

Skin irritation^{[14, 15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Skin irritation

Safety, Cautions & Contraindications

Safety note^{[15, 16]}Caution

Generally safe and well tolerated. High doses may cause low blood pressure and sedation. May interact with cardiac glycosides (digoxin) and antihypertensive drugs. Consult a physician before using with existing heart medications.

Safety note^{[15, 16, 17]}Info

Duke (2002) rates hawthorn (Crataegus spp., including C. laevigata) as a triple-plus herb (+++) with Commission E approval (score 2-3) for decreasing cardiac output in functional Stage II heart insufficiency (NYHA). Clinical evidence supports hawthorn standardized extracts (80-500 mg, standardized to flavonoids or procyanidins) for angina, arrhythmia, atherosclerosis, and hypertension. Hawthorn may potentiate digitalis and other cardiac medications and is not considered suitable for self-medication without professional guidance (Duke, 2002).

Safety note^{[14, 15, 16]}Caution

Generally well tolerated at standard doses. May cause mild digestive upset, dry mouth, or dizziness in some individuals. May enhance the effects of anticoagulant and antihypertensive medications. Avoid during pregnancy and breastfeeding. Extended use beyond 6 months is not well studied in humans.

Safety note^{[14, 15, 16, 17]}Caution

Duke (2002) rates reishi (Ganoderma lucidum) as + and notes immunostimulant, hepatoprotective, antioxidant, antitumor, and hypoglycemic activities at the experimental level (score 1). It is a key adaptogen in traditional Chinese medicine, valued for its polysaccharide (beta-glucan) content. Duke notes antiviral (score 1) and anti-aggregant activities. No strong clinical trials existed at time of publication, but lentinan and polysaccharide fractions from related species show immunomodulatory potential. Duke suggests caution in bleeding disorders due to anti-aggregant activity (Duke, 2002).

External Ids

Gbif: 8252683

Wikidata: Q159553

Gbif: 7690471

Wikidata: Q97958947

Botanical Description

Small deciduous tree or large shrub with thorny branches and glossy, shallowly lobed leaves (less deeply cut than common hawthorn). Clusters of small, five-petalled white (occasionally pink) flowers with a strong scent appear in spring, followed by small red berries (haws), each usually containing two seeds (nutlets).^[1]

Height: 4-8 m

Habit: Small deciduous, thorny tree or large shrub

Leaves: Glossy, shallowly lobed (less deeply cut than C. monogyna)

Flowers: Clusters of small, five-petalled white to pink, strongly scented flowers

Stem: Thorny branches; grey, fissured bark on older wood

Root: Deep, spreading root system

Fruit: Small red berry (haw), usually with two seeds

Flowering Period: April-May

Bracket (shelf) fungus (not a true plant) that grows on the trunks and stumps of deciduous trees. It develops a hard, kidney- or fan-shaped cap with a glossy, varnished, red-brown to mahogany crust and concentric growth rings, often on a lateral woody stalk; the pale underside is covered in fine pores that release rusty-brown spores. The mycelium spreads through the wood substrate before fruiting.^[1]

Height: Cap 5-20 cm across

Habit: Perennial wood-decay bracket fungus

Leaves: Not applicable (fungus)

Flowers: Not applicable (fungus); reproduces by spores

Stem: Hard, glossy, varnished kidney- or fan-shaped cap, often on a lateral stalk

Root: Mycelium spreading through the wood substrate

Fruit: Pale, finely pored underside releasing rusty-brown spores

Flowering Period: Fruiting body develops over weeks to months on the host wood

Habitat

Grows in woodland, woodland edges, hedgerows and scrub, typically on richer, damper soils than common hawthorn; native to western and central Europe.^[1]

Grows as a wood-decay fungus on the stumps and trunks of deciduous trees (notably maple and other hardwoods) in East Asian forests; also widely cultivated commercially on hardwood logs or sawdust substrate.

Harvesting

Flowers are picked as they open in spring, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn; all three parts are used, often combined, in hawthorn preparations.^[1]

Parts: Flower, Fruit, Leaf

Season: Flower and leaf in spring; fruit in autumn

Wild fruiting bodies are collected once mature; cultivated material is harvested from logs or substrate at maturity, then dried and processed into slices, powder or extract.

Parts: Mycelium, Whole Plant

Traditional Uses

Hawthorn flower, leaf and berry have a long European tradition, and substantial modern clinical study, as a cardiovascular tonic - supporting heart function, mild circulatory complaints and calming nervous tension - reflected in its traditional use for 'heart strengthening' and its modern standing as a well-studied botanical for mild heart failure symptoms.^[1]

Reishi/lingzhi, the 'mushroom of immortality', is one of the most revered tonic fungi in traditional Chinese medicine, used for centuries to support vitality, calm the spirit, strengthen immunity and promote longevity; this traditional tonic reputation is now studied for immunomodulatory, anticancer-adjunct and metabolic effects.^{[1, 4]}

Preparations

Standardised extract^[1]

Leaf-and-flower extract standardised to flavonoid or oligomeric proanthocyanidin content, taken as tablets or capsules; the best-studied clinical form.

Standardised extract^{[1, 4]}

Extract standardised to polysaccharide (beta-glucan) or triterpene content, taken as capsules or powder; the form used in most modern studies.

Dosage

Standardised extract^[14]

The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.

Herbal tea^[14]

The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.

Not documented

References

REF-0782, REF-0783, REF-0784, REF-1779, REF-1780, REF-1781, REF-1782, REF-1783, REF-1784, REF-1785, REF-1786, REF-1787, REF-1788

REF-0821, REF-0822, REF-0823, REF-2039, REF-2040, REF-2041, REF-2042, REF-2043, REF-2044, REF-2045, REF-2046, REF-2047, REF-2048

Drug Class Interactions

Safety note^{[18, 19, 20]}Caution

Drug Class: cardiac-glycosides

Mechanism: Hawthorn has its own positive effect on the heart (a Cochrane review found it improves heart-failure symptoms and exercise tolerance) and shares P-glycoprotein handling with digoxin, so combining it with digoxin or other cardiac-glycoside heart drugs should be supervised even though a controlled study found no major change in digoxin levels.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-03

Safety note^{[19, 20]}Caution

Drug Class: antihypertensives

Mechanism: Hawthorn can mildly lower blood pressure and reduce cardiac oxygen demand (a Cochrane meta-analysis found a lower pressure-heart-rate product), which may add to the effect of blood-pressure and heart-failure medicines.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-03

Safety note^{[21, 22]}Caution

Drug Class: sedatives-cns-depressants

Mechanism: Hawthorn is traditionally used as a calming, sedative herb; taken with sedatives, sleeping tablets or other central-nervous-system depressants (including alcohol) it may add to drowsiness and slowed reactions.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-03

Safety note^{[18, 19]}Caution

Drug Class: sedatives-cns-depressants

Mechanism: Reishi is traditionally used as a calming, sedative herb; taken with sedatives, sleeping tablets or other central-nervous-system depressants (including alcohol) it may add to drowsiness and slowed reactions.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-03

Lookalikes Review

Outcome: none-known

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

Outcome: has-lookalikes

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

Dangerous Lookalikes

Not documented

Safety note^{[20, 21]}Fatal

Dangerous Plant: podostroma-cornu-damae

Confused Part: Wild-collected fruit bodies gathered as reishi/lingzhi for medicinal tea; the immature red, antler-like fruit bodies of poison fire coral can be taken for young reishi.

Confusion Context: Reishi (Ganoderma lingzhi / lucidum) is a hard, varnished bracket fungus collected and brewed as a health tonic. Poison fire coral (Podostroma cornu-damae), one of the few deadly-poisonous fungi, is documented to resemble Ganoderma lucidum in its immature stage. A peer-reviewed case report (Ahn et al., 2013, Yonsei Med J) describes two people who collected and boiled wild fungus as tea - one died of pancytopenia and multiple organ failure - and states that in its immature period poison fire coral resembles Ganoderma lucidum, 'well known as a health-food.' Its trichothecene mycotoxins (satratoxins) are frequently fatal. Because reishi is wild-collected for medicinal tea in East Asia, this is a genuinely lethal confusion.

Distinguishing Features: Colour and form: poison fire coral is bright blood-red to orange-red and grows as erect, often branched antler- or coral-like clubs rising from the ground or buried wood. True reishi is a flat kidney- or fan-shaped bracket (conk) with a hard, glossy, varnished red-brown to mahogany crust and a pale pored underside, growing on wood., Growth pattern: reishi forms a shelf/bracket with a distinct cap and often a lateral stalk; poison fire coral forms finger-like or antler-like red spikes with no cap., Underside: reishi has a white-to-brown pored underside that drops rusty-brown spores; poison fire coral has no pores at all.

Key Test: Look at the shape. Reishi is a hard, flat, varnished shelf/bracket with a pale pored underside, growing on wood. Any bright red, erect antler- or coral-like club with NO cap and NO pores is NOT reishi - it may be poison fire coral (Podostroma cornu-damae), which can kill. Never brew an unfamiliar red club or coral fungus; if unsure, do not use it and confirm with an expert mycologist.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

References & Sources

Fong, H.H.S. and Bauman, J.L (2002) 'Hawthorn', Journal of Cardiovascular Nursing, 16(4), pp. 1-8. doi:10.1097/00005082-200207000-00002 Traditional / reference
https://doi.org/10.1097/00005082-200207000-00002
Orhan, I.E (2018) 'Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb', Current Medicinal Chemistry, 25(37), pp. 4854-4865. doi:10.2174/0929867323666160919095519 Traditional / reference
https://doi.org/10.2174/0929867323666160919095519
Ahmadipour, B., Kalantar, M., Abaszadeh, S. and Hassanpour, H (2024) 'Antioxidant and antihyperlipidemic effects of hawthorn extract (Crataegus oxyacantha) in broiler chickens', Veterinary Medicine and Science, 10(3), pp. e1414. doi:10.1002/vms3.1414 Preclinical
https://doi.org/10.1002/vms3.1414
Rigelsky, J.M. and Sweet, B.V (2002) 'Hawthorn: pharmacology and therapeutic uses', American Journal of Health-System Pharmacy, 59(5), pp. 417-422. doi:10.1093/ajhp/59.5.417 Meta-analysis / review
https://doi.org/10.1093/ajhp/59.5.417
Saeedi, G., Jeivad, F., Goharbari, M., Gheshlaghi, G.H. and Sabzevari, O (2018) 'Ethanol Extract of Crataegus Oxyacantha L. Ameliorate Dietary Non-Alcoholic Fatty Liver Disease in Rat', Drug Research, 68(10), pp. 553-559. doi:10.1055/a-0579-7532 Preclinical
https://doi.org/10.1055/a-0579-7532
Mecheri, A., Benabderrahmane, W., Amrani, A., Boubekri, N., Benayache, F., Benayache, S. and Zama, D (2019) 'Hepatoprotective Effects of Algerian Crataegus oxyacantha Leaves', Recent Patents on Food, Nutrition & Agriculture, 10(1), pp. 70-75. doi:10.2174/2212798410666180730095456 Preclinical
https://doi.org/10.2174/2212798410666180730095456
Benabderrahmane, W., Lores, M., Benaissa, O., Lamas, J.P., de Miguel, T., Amrani, A., Benayache, F. and Benayache, S (2019) 'Polyphenolic content and bioactivities of Crataegus oxyacantha L. (Rosaceae)', Natural Product Research, 35(4), pp. 627-632. doi:10.1080/14786419.2019.1582044 Preclinical
https://doi.org/10.1080/14786419.2019.1582044
Ali, M., Muhammad, S., Shah, M.R., Khan, A., Rashid, U., Farooq, U., Ullah, F., Sadiq, A., Ayaz, M., Ali, M., Ahmad, M. and Latif, A (2017) 'Neurologically Potent Molecules from Crataegus oxyacantha; Isolation, Anticholinesterase Inhibition, and Molecular Docking', Frontiers in Pharmacology, 8, pp. 327. doi:10.3389/fphar.2017.00327 Preclinical
https://doi.org/10.3389/fphar.2017.00327
Cuevas-Duran, R.E., Medrano-Rodriguez, J.C., Sanchez-Aguilar, M., Soria-Castro, E., Rubio-Ruiz, M.E., Del Valle-Mondragon, L., Sanchez-Mendoza, A., Torres-Narvaez, J.C., Pastelin-Hernandez, G. and Ibarra-Lara, L (2017) 'Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents', International Journal of Molecular Sciences, 18(11), pp. 2412. doi:10.3390/ijms18112412 Preclinical
https://doi.org/10.3390/ijms18112412
Alp, H., Soner, B.C., Baysal, T. and Sahin, A.S (2014) 'Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats', Anatolian Journal of Cardiology, 15(12), pp. 970-975. doi:10.5152/akd.2014.5869 Preclinical
https://doi.org/10.5152/akd.2014.5869
Rothfuss, M.A., Pascht, U. and Kissling, G (2001) 'Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats', Arzneimittel-Forschung, 51(1), pp. 24-28. doi:10.1055/s-0031-1299998 Preclinical
https://doi.org/10.1055/s-0031-1299998
Khan, A., Akram, M., Thiruvengadam, M., Daniyal, M., Zakki, S.A., Munir, N., Zainab, R., Heydari, M., Mosavat, S.H., Rebezov, M. and Shariati, M.A (2022) 'Anti-anxiety Properties of Selected Medicinal Plants', Current Pharmaceutical Biotechnology, 23(8), pp. 1041-1060. doi:10.2174/1389201022666210122125131 Meta-analysis / review
https://doi.org/10.2174/1389201022666210122125131
Rastogi, S., Pandey, M.M. and Rawat, A.K.S (2015) 'Traditional herbs: a remedy for cardiovascular disorders', Phytomedicine, 23(11), pp. 1082-1089. doi:10.1016/j.phymed.2015.10.012 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2015.10.012
European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore
Hendel, N. and Hendel, M (2014) 'Hedgerow Medicine'. Traditional / reference
https://scholar.google.com/scholar?q=Hedgerow%20Medicine
Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure
Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
https://doi.org/10.1177/0091270003253417
Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2
Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2
Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201
Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003

Li, W., Zhou, Q., Lv, B., Li, N. et al (2024) 'Ganoderma lucidum Polysaccharide Supplementation Significantly Activates T-Cell-Mediated Antitumor Immunity and Enhances Anti-PD-1 Immunotherapy Efficacy in Colorectal Cancer', Journal of Agricultural and Food Chemistry, 72(21), pp. 12072-12082. doi:10.1021/acs.jafc.3c08385 Preclinical
https://doi.org/10.1021/acs.jafc.3c08385
Cai, Q., Li, Y. and Pei, G (2017) 'Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response', Journal of Neuroinflammation, 14(1), pp. 63. doi:10.1186/s12974-017-0839-0 Preclinical
https://doi.org/10.1186/s12974-017-0839-0
Zheng, G., Zhao, Y., Li, Z., Hua, Y. et al (2023) 'Ganoderma lucidum spore powder and derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis', Theranostics, 13(4), pp. 1325-1341. doi:10.7150/thno.80250 Preclinical
https://doi.org/10.7150/thno.80250
Sohretoglu, D. and Huang, S (2018) 'Ganoderma lucidum Polysaccharides as An Anti-cancer Agent', Anti-Cancer Agents in Medicinal Chemistry, 18(5), pp. 667-674. doi:10.2174/1871520617666171113121246 Meta-analysis / review
https://doi.org/10.2174/1871520617666171113121246
Seweryn, E., Ziala, A. and Gamian, A (2021) 'Health-Promoting of Polysaccharides Extracted from Ganoderma lucidum', Nutrients, 13(8), pp. 2725. doi:10.3390/nu13082725 Meta-analysis / review
https://doi.org/10.3390/nu13082725
Liu, X., Yang, L., Li, G., Jiang, Y., Zhang, G. and Ling, J (2022) 'A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide', International Journal of Biological Macromolecules, 229, pp. 168-180. doi:10.1016/j.ijbiomac.2022.12.276 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2022.12.276
Zhu, M., Chang, Q., Wong, L.K., Chong, F.S. and Li, R.C (1999) 'Triterpene antioxidants from Ganoderma lucidum', Phytotherapy Research, 13(6), pp. 529-531. doi:10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x Preclinical
https://doi.org/10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x
Zeng, P., Chen, Y., Zhang, L. and Xing, M (2019) 'Ganoderma lucidum polysaccharide used for treating physical frailty in China', Progress in Molecular Biology and Translational Science, 163, pp. 179-219. doi:10.1016/bs.pmbts.2019.02.009 Meta-analysis / review
https://doi.org/10.1016/bs.pmbts.2019.02.009
Wu, P., Zhang, C., Yin, Y., Zhang, X., Li, Q., Yuan, L., Sun, Y., Zhou, S., Ying, S. and Wu, J (2024) 'Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review', Heliyon, 10(19), pp. e36987. doi:10.1016/j.heliyon.2024.e36987 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e36987
Xu, Z., Chen, X., Zhong, Z., Chen, L. and Wang, Y (2011) 'Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities', The American Journal of Chinese Medicine, 39(1), pp. 15-27. doi:10.1142/S0192415X11008610 Meta-analysis / review
https://doi.org/10.1142/S0192415X11008610
Geng, X., Zhong, D., Su, L., Lin, Z. and Yang, B (2019) 'Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases', Advances in Pharmacology, 87, pp. 257-276. doi:10.1016/bs.apha.2019.10.003 Meta-analysis / review
https://doi.org/10.1016/bs.apha.2019.10.003
Sliva, D (2004) 'Cellular and physiological effects of Ganoderma lucidum (Reishi)', Mini Reviews in Medicinal Chemistry, 4(8), pp. 873-879. doi:10.2174/1389557043403323 Meta-analysis / review
https://doi.org/10.2174/1389557043403323
Boh, B., Berovic, M., Zhang, J. and Zhi-Bin, L (2007) 'Ganoderma lucidum and its pharmaceutically active compounds', Biotechnology Annual Review, 13, pp. 265-301. doi:10.1016/S1387-2656(07)13010-6 Meta-analysis / review
https://doi.org/10.1016/S1387-2656(07)13010-6
Bao, X. et al (2001) 'Structural requirements for the immunological activities of polysaccharides from Ganoderma lucidum', 41(9), pp. 2603--2611. Traditional / reference
https://scholar.google.com/scholar?q=Structural%20requirements%20for%20the%20immunological%20activities%20of%20polysaccharides%20from%20Ganoderma%20lucidum
Jin, X. et al (2012) 'Ganoderma lucidum (Reishi mushroom) for cancer treatment'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Reishi%20mushroom%29%20for%20cancer%20treatment
Wachtel-Galor, S., Yuen, J., Buswell, J.A. and Benzie, I.F.F (2011) 'Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Lingzhi%20or%20Reishi%29%3A%20A%20Medicinal%20Mushroom
Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201
Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
Ahn, J.Y. and Seok, S.J. and Song, J.E. and Choi, J.H. and Han, S.H. and Choi, J.Y. and Kim, C.O. and Song, Y.G. and Kim, J.M (2013) 'Two cases of mushroom poisoning by Podostroma cornu-damae', Yonsei Medical Journal, 54(1), pp. 265-8. doi:10.3349/ymj.2013.54.1.265 Clinical study
https://doi.org/10.3349/ymj.2013.54.1.265
Choe, S. and In, S. and Jeon, Y. and Choi, H. and Kim, S (2018) 'Identification of trichothecene-type mycotoxins in toxic mushroom Podostroma cornu-damae and biological specimens from a fatal case by LC-QTOF/MS', Forensic Science International, 291, pp. 234-244. doi:10.1016/j.forsciint.2018.08.043 Clinical study
https://doi.org/10.1016/j.forsciint.2018.08.043

Midland Hawthorn monograph Lingzhi monograph Compare other plants

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.